| Literature DB >> 35493842 |
Xinxin Qiao1,2, Jinfeng Duan3,4, Nan Zhang1, Yang Duan1, Xinrui Wang1, Yusong Pei1, Zhihua Xu1,5, Benqiang Yang1, Miao Qi1, Jinze Li2.
Abstract
Objective: To quantitatively evaluate the impaired perfusion status of patients with symptomatic internal carotid artery (ICA) steno-occlusive disease and to explore the risk factors of impaired perfusion with computed tomography perfusion (CTP).Entities:
Keywords: CT perfusion; circle of Willis; impaired perfusion; internal carotid artery; internal watershed
Year: 2022 PMID: 35493842 PMCID: PMC9046650 DOI: 10.3389/fneur.2022.801413
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Figure 1Flowchart of study population enrollment.
Figure 2Representative images of patients without or with impaired perfusion. (A–C) A 65-year-old female patient was hospitalized with mild headache and was diagnosed as severe stenosis of the right internal carotid artery (ICA) by digital subtraction angiography (DSA) (A). The patient had no impaired perfusion. In the right internal watershed, cerebral blood flow (CBF) (B) decreased slightly, cerebral blood volume (CBV) (C) increased slightly, and CBF/CBV > 7.55/min. (D–F) A 73-year-old male patient was hospitalized with poor left limb activity, and was diagnosed as severe stenosis of the right ICA by DSA (D). The patient had impaired perfusion. In the right internal watershed, CBF (E) decreased, and CBV (F) decreased slightly, and CBF/CBV < 7.55/min.
Figure 3The morphology variants of the circle of Willis in a patient with severe stenosis of left ICA. (A) Complete circle of Willis (type I); (B) no ipsilateral posterior communicating artery (PCoA) (type II); (C) ipsilateral fetal-type posterior cerebral artery (FTP) (type II); (D) no ipsilateral in the first segment of the anterior cerebral artery (ACA-A1) (type III); (E) no ipsilateral PCoA and incomplete anterior circulation (type IV); and (F) ipsilateral fetal-type posterior (FTP) and incomplete anterior circulation (type IV).
Univariate analysis of factors associated with impaired perfusion.
|
|
|
|
| |
|---|---|---|---|---|
| Age | 66 ± 8 | 64 ± 7 | 1.787 | 0.076 |
| Male gender | 81 (92.0%) | 86 (86.9%) | 1.307 | 0.253 |
| Hypertension | 59 (67.0%) | 67 (67.7%) | 0.008 | 0.927 |
| Hyperlipidemia | 40 (45.5%) | 44 (44.4%) | 0.019 | 0.890 |
| HHcy | 19 (21.6%) | 32 (32.3%) | 2.705 | 0.100 |
| Diabetes | 34 (38.6%) | 34 (34.3%) | 0.371 | 0.542 |
| CHD | 13 (14.8%) | 20 (20.2%) | 0.945 | 0.331 |
| AF | 3 (3.4%) | 5 (5.1%) | 0.725 | |
| Stroke history | 21 (23.9%) | 17 (17.2%) | 1.289 | 0.256 |
| Current smoking | 58 (65.9%) | 74 (74.7%) | 1.753 | 0.186 |
| Alcohol use | 36 (40.9%) | 53 (53.5%) | 2.978 | 0.084 |
|
| ||||
| SBP | 144 ±16 | 135 ± 18 | 3.525 | 0.001 |
| DBP | 84 ± 9 | 79 ± 9 | 3.583 | <0.001 |
| MAP | 104 ± 10 | 98 ± 11 | 4.024 | <0.001 |
| LVEF | 0.63 ± 0.03 | 0.64 ± 0.03 | −1.948 | 0.053 |
|
| 3.761 | 0.288 | ||
| Grade I | 24 (27.3%) | 18 (18.2%) | ||
| Grade II | 24 (27.3%) | 23 (23.2%) | ||
| Grade III | 26 (29.5%) | 35 (35.4%) | ||
| Grade IV | 14 (15.9%) | 23 (23.2 %) | ||
|
| 13.024 | 0.005 | ||
| Type I | 30 (34.1%) | 16 (16.2%) | ||
| Type II | 31 (35.2%) | 35 (35.4%) | ||
| Type III | 15 (17.0%) | 16 (16.2%) | ||
| Type IV | 12 (13.6%) | 32 (32.3%) | ||
|
| 26.405 | <0.001 | ||
| Asymptomatic | 54 (61.4%) | 24 (24.2%) | ||
| Symptomatic | 34 (38.6%) | 75 (75.8%) |
HHcy, hyperhomocysteinemia; CHD, coronary heart disease; AF, atrial fibrillation; BP, blood pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; LVEF, left ventricular ejection fraction.
Logistic regression analysis of factors associated with impaired perfusion.
|
|
|
| ||
|---|---|---|---|---|
| MAP | <0.001 | 0.946 | 0.917 | 0.974 |
|
| ||||
| Type I vs. type II | 0.055 | 2.190 | 0.982 | 4.884 |
| Type I vs. type III | 0.160 | 1.998 | 0.761 | 5.243 |
| Type I vs. type IV | 0.001 | 4.987 | 1.955 | 12.723 |
OR, odds ratio; 95% CI, 95% confidential interval; MAP, mean arterial pressure.
Comparison of computed tomography perfusion (CTP) parameters between healthy and affected sides.
|
|
| |||
|---|---|---|---|---|
|
|
|
|
| |
|
| ||||
| CBF, mL/100 g/min | 0.699 (0.631, 0.773) | <0.001 | 0.807 (0.723, 0.902) | <0.001 |
| CBV, mL/100 g | 1.055 (0.620, 1.795) | 0.843 | ||
| CBF/CBV, per min | 0.369 (0.286, 0.478) | <0.001 | 0.408 (0.309, 0.539) | <0.001 |
|
| ||||
| CBF, mL/100 g/min | 0.919 (0.839, 1.008) | 0.072 | ||
| CBV, mL/100 g | 0.641 (0.258, 1.591) | 0.338 | ||
| CBF/CBV, per min | 0.919 (0.809, 1.044) | 0.192 | ||
Comparison of CTP parameters between asymptomatic and symptomatic patients.
|
|
| |||
|---|---|---|---|---|
|
|
|
|
| |
|
| ||||
| CBF, mL/100 g/min | 1.023 (0.944, 1.108) | 0.585 | ||
| CBV, mL/100 g | 1.293 (0.658, 2.543) | 0.456 | ||
| CBF/CBV, per min | 0.963 (0.839, 1.106) | 0.595 | ||
|
| ||||
| CBF, mL/100 g/min | 0.792 (0.719, 0.873) | <0.001 | 0.929 (0.821, 1.050) | 0.237 |
| CBV, mL/100 g | 2.027 (0.953, 4.311) | 0.066 | ||
| CBF/CBV, per min | 0.484 (0.377, 0.622) | <0.001 | 0.513 (0.393, 0.670) | <0.001 |
Univariate and multivariate analysis of factors associated with symptomatic patients.
|
|
| |||
|---|---|---|---|---|
|
|
|
|
| |
| Age | 1.008 (0.970, 1.047) | 0.683 | ||
| Male gender | 0.687 (0.271, 1.740) | 0.428 | ||
| Hypertension | 0.781 (0.418, 1.461) | 0.440 | ||
| Hyperlipidemia | 1.435 (0.796, 2.586) | 0.229 | ||
| HHcy | 1.627 (0.830, 3.189) | 0.157 | ||
| Diabetes | 0.856 (0.469, 1.565) | 0.614 | ||
| CHD | 1.124 (0.521, 2.422) | 0.766 | ||
| AF | 1.202 (0.279, 5.185) | 0.805 | ||
| Stroke history | 0.856 (0.418, 1.756) | 0.672 | ||
| Current smoking | 1.332 (0.713, 2.489) | 0.369 | ||
| Alcohol use | 1.206 (0.673, 2.161) | 0.529 | ||
|
| ||||
| SBP | 0.997 (0.981, 1.014) | 0.736 | ||
| DBP | 0.970 (0.940, 1.001) | 0.055 | ||
| MAP | 0.982 (0.956, 1.009) | 0.192 | ||
| LVEF | 0.002 (0.000, 30.489) | 0.210 | ||
|
| 1.194 (0.903, 1.579) | 0.214 | ||
| Grade I | ||||
| Grade II | ||||
| Grade III | ||||
| Grade IV | ||||
|
| 1.389 (1.055, 1.828) | 0.019 | 1.176 (0.856, 1.615) | 0.318 |
| Type I | ||||
| Type II | ||||
| Type III | ||||
| Type IV | ||||
| CBF/CBV | 0.517 (0.409, 0.655) | <0.001 | 0.528 (0.416, 0.669) | <0.001 |
HHcy, hyperhomocysteinemia; CHD, coronary heart disease; AF, atrial fibrillation; BP, blood pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; LVEF, left ventricular ejection fraction.
Figure 4The area under the receiver operating characteristic (ROC) curve predicts impaired perfusion in patients with symptomatic ICA steno-occlusive disease.
Figure 5Comparison of the differences of the CBF/CBV value among different vascular variants of the circle of Willis. Different vascular variants of the circle of Willis: 1 = no variation; 2 = no ipsilateral PCoA; 3 = ipsilateral FTP; 4 = no ipsilateral ACA-A1; 5 = no ipsilateral PCoA and incomplete anterior circulation; 6 = ipsilateral FTP and incomplete anterior circulation.